North America Clinical Laboratory Services Market, By Service Type (Routine Testing Services, Esoteric Services, and Anatomic Pathology Services), Specialty (Clinical Chemistry Testing, Hematology Testing, Microbiology Testing, Immunology Testing, Drugs of Abuse Testing, Cytology Testing, and Genetic Testing), Provider (Hospital-Based Laboratories, Independent and Reference Laboratories, Nursing and Physician Office-Based Laboratories), Application (Drug Discovery Related Services, Drug Development Related Services, Bioanalytical and Lab Chemistry Services, Toxicology Testing Services, Cell and Gene Therapy Related Services, Preclinical and Clinical Trial Related Services and Other Clinical Laboratory Service) – Industry Trends and Forecast to 2031.
North America Clinical Laboratory Services Market Analysis and Size
The clinical laboratory services market encompasses independent and reference laboratories, hospital-based laboratories, and nursing and physician office-based laboratories. Independent labs such as Quest Diagnostics offer comprehensive testing services. Hospital-based labs, such as those in Mayo Clinic, provide diagnostic support to inpatient care. Nursing and physician office-based labs such as LabCorp offer convenient testing facilities for outpatient services, catering to diverse healthcare needs.
Data Bridge Market Research analyses that the North America clinical laboratory services market, which was USD 1,27,237.23 million in 2023, is expected to reach USD 2,23,569.21 million by 2031, at a CAGR of 7.3% during the forecast period 2024 to 2031. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
North America Clinical Laboratory Services Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Service Type (Routine Testing Services, Esoteric Services, and Anatomic Pathology Services), Specialty (Clinical Chemistry Testing, Hematology Testing, Microbiology Testing, Immunology Testing, Drugs of Abuse Testing, Cytology Testing, and Genetic Testing), Provider (Hospital-Based Laboratories, Independent and Reference Laboratories, Nursing and Physician Office-Based Laboratories), Application (Drug Discovery Related Services, Drug Development Related Services, Bioanalytical and Lab Chemistry Services, Toxicology Testing Services, Cell and Gene Therapy Related Services, Preclinical and Clinical Trial Related Services and Other Clinical Laboratory Service)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America
|
|
Market Players Covered
|
BD (U.S.), Genomic Health (U.S.), Abbott (U.S.), Charles River (U.S.), H.U. Group Holdings, Inc. (China), Eurofins Scientific (Luxembourg), Laboratory Corporation of America Holding (U.S.), Mayo Foundation for Medical Education and Research (U.S.), DaVita Inc. (U.S.), Quest Diagnostics Incorporated (U.S.), Siemens Healthcare GmbH (Germany), ARUP Laboratories (U.S.), Lifelabs (Canada), BioReference Laboratories, Inc. (U.S.), NeoGenomics Laboratories, Inc. (U.S.), ACM Global Laboratories (U.S.), Sartorius AG (Germany)
|
|
Market Opportunities
|
|
Market Definition
Clinical laboratory services refer to diagnostic procedures performed on patient specimens to assess health status or disease presence. These services encompass a wide range of tests including blood analysis, microbiology cultures, and genetic assays, providing vital information for medical decision-making and patient care in healthcare settings.
North America Clinical Laboratory Services Market Dynamics
Drivers
- Technological Innovations Enhance Efficiency and Accuracy
Technological innovations continually enhance the efficiency and accuracy of diagnostic testing procedures, leading to improved patient outcomes and streamlined healthcare processes. From automated testing systems to advanced analytical instruments, such innovations enable laboratories to handle larger volumes of tests with greater precision, meeting the increasing demand for diagnostic services in a rapidly evolving healthcare landscape.
- Aging Population Requires More Diagnostic Testing
Individuals aging necessitate increased diagnostic testing to monitor and manage age-related health conditions such as cardiovascular disease, diabetes, and cancer. This demographic shift drives demand for laboratory services, as healthcare providers emphasize preventive care and early disease detection. Consequently, the clinical laboratory services market experiences sustained growth, propelled by the imperative to address the evolving healthcare needs of an aging population.
Opportunities
- Partnering with Pharmaceutical Companies for Clinical Trials
Through collaborating, laboratories can provide specialized testing services required for drug development, efficacy, and safety assessments. This partnership allows laboratories to expand their clientele, gain access to cutting-edge research, and establish themselves as key players in the pharmaceutical industry. Additionally, it fosters innovation and contributes to advancements in healthcare, ultimately driving growth and profitability in the market.
- Expansion of Testing Services to Rural Areas
Reaching underserved communities enables laboratories to fulfill unmet healthcare needs, enhancing overall patient care and access to diagnostic testing. This expansion opens new markets, boosts revenue streams, and bolsters the laboratory's reputation for serving diverse populations. Moreover, it aligns with healthcare equity goals, displaying social responsibility and nurturing long-term sustainability and growth within the market.
Restraints/Challenges
- Regulatory Compliance Complexities Hinder Operational Efficiency
Stricter regulations increase administrative burdens, leading to longer processing times and higher operational costs. This can result in delays in test reporting, reduced throughput capacity, and overall inefficiencies in laboratory operations. Ultimately, these challenges may limit the ability of laboratory providers to meet the growing demand for diagnostic services, potentially impacting market growth and profitability.
- Data Security and Privacy Concerns Impede Digitalization Efforts
Heightened scrutiny over the protection of sensitive patient information slows down the adoption of digital technologies and cloud-based solutions. This impediment delays the implementation of streamlined processes, inhibiting efficiency gains and limiting scalability. Additionally, reluctance to digitize may hinder collaboration and data sharing among healthcare providers, impacting the delivery of integrated care and potentially hinder market advancement.
This North America clinical laboratory services market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the North America clinical laboratory services market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In 2023, DiaCarta, Ltd. collaborated with Hopkins MedTech Lab Services and Hopkins MedTech Compliance to aid in the development and validation of laboratory-developed tests (LDTs) in the United States. This partnership aimed to bolster DiaCarta's presence in the clinical laboratory services market, facilitating the advancement and regulatory compliance of their testing capabilities
- In 2023, Laboratory Corporation of America Holdings (Labcorp) entered an agreement with Tufts Medicine to acquire its Outreach Laboratory Business. This strategic move aimed to expand Labcorp's diagnostic testing and laboratory services offerings, further solidifying its position in the healthcare industry and enhancing its ability to meet the evolving needs of patients and healthcare providers
- In February 2023, Detact Diagnostics, a Dutch biotech company, established a new laboratory at Keene State College (U.S.) under a 2-year rental contract. This expansion aimed to strengthen Detact Diagnostics' presence in the clinical laboratory services market, enabling enhanced research and development capabilities for diagnostic technologies and services
- In 2021, Mayo Clinic Laboratories became a United Healthcare Preferred Lab Network (PLN) care provider, offering in-network access to comprehensive subspecialty testing for United Healthcare members. This accreditation bolstered the company's popularity in subspecialty testing within the clinical laboratory services market, expanding its reach and reputation among healthcare providers and patients alike
North America Clinical Laboratory Services Market Scope
The North America clinical laboratory services market is segmented on the basis of service type, speciality, provider and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Service Type
- Routine Testing Services
- Esoteric Services
- Anatomic Pathology Services
Speciality
- Clinical Chemistry Testing
- Hematology Testing
- Microbiology Testing
- Immunology Testing
- Drugs of Abuse Testing
- Cytology Testing
- Genetic Testing
Provider
- Hospital-Based Laboratories
- Independent and Reference Laboratories
- Nursing and Physician Office-Based Laboratories
Application
- Bioanalytical and Lab Chemistry Services
- Drug Development Related Services
- Drug Discovery Related Services
- Toxicology Testing Services
- Cell and Gene Therapy Related Services
- Preclinical and Clinical Trial Related Services
- Other Clinical Laboratory Services
North America Clinical Laboratory Services Market Regional Analysis/Insights
The North America clinical laboratory services market is analysed and market size insights and trends are provided by service type, speciality, provider and application as referenced above.
The countries covered in the North America clinical laboratory services market report are U.S., Canada and Mexico in North America.
The U.S. leads the clinical laboratory services market, propelled by escalating demand for timely and precise disease detection. The nation's advanced healthcare infrastructure, technological innovations, and emphasis on preventive medicine contribute to its dominance. This leadership position is further bolstered by a growing focus on early intervention and comprehensive healthcare delivery systems.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The North America clinical laboratory services market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for North America clinical laboratory services market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the North America clinical laboratory services market. The data is available for historic period 2016-2021.
Competitive Landscape and North America Clinical Laboratory Services Market Share Analysis
The North America clinical laboratory services market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to North America clinical laboratory services market.
Some of the major players operating in the North America clinical laboratory services market are:
- BD (U.S.)
- Genomic Health (U.S.)
- Abbott (U.S.)
- Charles River (U.S.)
- H.U. Group Holdings, Inc. (China)
- Eurofins Scientific (Luxembourg)
- Laboratory Corporation of America Holding (U.S.)
- Mayo Foundation for Medical Education and Research (U.S.)
- DaVita Inc. (U.S.)
- Quest Diagnostics Incorporated (U.S.)
- Siemens Healthcare GmbH (Germany)
- ARUP Laboratories (U.S.)
- Lifelabs (Canada)
- BioReference Laboratories, Inc. (U.S.)
- NeoGenomics Laboratories, Inc. (U.S.)
- ACM Global Laboratories (U.S.)
- Sartorius AG (Germany)
SKU-